CellFE(r) Announces Launch of First-in-Class T-Rest(tm) (“Resting T Cell Kit”) for Breakthrough CAR-T Cell Therapy Manufacturing

CellFE, a leader in non-viral gene editing technology, today announced the launch of its highly anticipated CellFE T-Rest (“Resting T Cell Kit”), a first-in-class cell manufacturing transfection media product designed specifically for resting (quiescent) T cell workflows. 

Read More